# Coincidence of autosomal dominant polycystic kidney disease and Alport syndrome: a case report and literature review

**Authors:** Rui Liu, Fei Liu

PMC · DOI: 10.1007/s13730-025-01057-3 · CEN Case Reports · 2026-01-20

## TL;DR

A rare case of a child with both ADPKD and Alport syndrome is reported, highlighting the importance of genetic testing for accurate diagnosis and treatment.

## Contribution

This paper presents a rare co-occurrence of ADPKD and Alport syndrome and reviews similar cases to emphasize diagnostic and prognostic challenges.

## Key findings

- A 4-year-old boy presented with ADPKD and Alport syndrome, confirmed by genetic testing for COL4A5 and PKD1.
- Four previously reported cases showed similar features, with three progressing to kidney failure.
- Early genetic testing and comprehensive clinical evaluation are critical for managing these co-occurring conditions.

## Abstract

Autosomal dominant polycystic kidney disease (ADPKD) is the most common genetic kidney disease, accounting for approximately 5% of kidney failure worldwide. While Alport syndrome (AS) is an inherited progressive disease that typically presents with microhematuria in childhood and subsequently progresses to hematuria, proteinuria, and progressive renal impairment. The coexistence of ADPKD and AS is rare. Here, we present a case of a child with ADPKD and AS who presented with bilateral renal cysts and hematuria. Furthermore, we described the clinical and genetic characteristics of the present case and summarized the above features of previously reported cases. A 4-year-old boy had persistent microscopic hematuria and intermittent gross hematuria for 1 year. During routine examinations, microscopic hematuria (++), bilateral renal cysts, and high-frequency hearing loss were discovered. Furthermore, His mother had microscopic hematuria and was later diagnosed with ADPKD. A pathogenic variant was found in COL4A5 through genetic testing, while a variant of undermined significance (VUS) was discovered in PKD1. These clinical and genetic findings are consistent with the diagnosis of ADPKD and AS co-occurring. Enalapril was administered. A 2-year follow-up revealed that the patient had continuous microscopic hematuria and normal range renal function. We also reviewed four cases of ADPKD and AS coexisting. Moreover, hematuria and decreased renal function were the most common clinical features. They all had a positive family history. This disease has a poor prognosis, with three cases progressing to kidney failure. ADPKD and AS are often associated with hematuria, renal cysts, and decreased renal function. Comprehensive clinical information and early genetic testing is critical for diagnosis, prognostic stratification, and initiating targeted therapies to delay progression.

The online version contains supplementary material available at 10.1007/s13730-025-01057-3.

## Linked entities

- **Genes:** COL4A5 (collagen type IV alpha 5 chain) [NCBI Gene 1287], PKD1 (polycystin 1, transient receptor potential channel interacting) [NCBI Gene 5310]
- **Diseases:** autosomal dominant polycystic kidney disease (MONDO:0004691), Alport syndrome (MONDO:0018965), kidney failure (MONDO:0001106)

## Full-text entities

- **Genes:** PKD1 (polycystin 1, transient receptor potential channel interacting) [NCBI Gene 5310] {aka PBP, PC1, Pc-1, TRPP1, eliosin}, COL4A5 (collagen type IV alpha 5 chain) [NCBI Gene 1287] {aka ASLN, ATS, ATS1, CA54}
- **Diseases:** ADPKD (MESH:D016891), kidney failure (MESH:D051437), inherited progressive disease (MESH:D030342), renal cysts (MESH:D003560), proteinuria (MESH:D011507), AS (MESH:D009394), high-frequency hearing loss (MESH:D006316), genetic kidney disease (MESH:D007674), hematuria (MESH:D006417)
- **Chemicals:** Enalapril (MESH:D004656)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12819896/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12819896/full.md

---
Source: https://tomesphere.com/paper/PMC12819896